Table 1 Clinicopathological characteristics of BC patients in this study.
Variables | Training cohort (n = 405) | Validation cohort (n = 423) | p value | ||
---|---|---|---|---|---|
No | % | No | % | ||
Age | |||||
< 60 | 219 | 54.1 | 239 | 56.5 | 0.527 |
≥ 60 | 186 | 45.9 | 184 | 43.5 | |
T | |||||
T1 | 114 | 28.1 | 120 | 28.4 | 0.554 |
T2 | 226 | 55.8 | 229 | 54.2 | |
T3 | 46 | 11.4 | 61 | 14.4 | |
T4 | 17 | 4.2 | 12 | 2.8 | |
Tx | 2 | 0.5 | 1 | 0.2 | |
N | |||||
N0 | 189 | 46.7 | 187 | 44.2 | 0.397 |
N1 | 143 | 35.3 | 145 | 34.3 | |
N2 | 35 | 8.6 | 53 | 12.5 | |
N3 | 29 | 7.2 | 32 | 7.6 | |
Nx | 9 | 2.2 | 6 | 1.4 | |
M | |||||
M0 | 333 | 82.2 | 360 | 85.1 | 0.384 |
M1 | 9 | 2.2 | 11 | 2.6 | |
Mx | 63 | 15.6 | 52 | 12.3 | |
Stage | |||||
Stage I | 81 | 20.0 | 73 | 17.3 | 0.356 |
Stage II | 226 | 55.8 | 225 | 53.2 | |
Stage III | 79 | 19.5 | 106 | 25.0 | |
Stage IV | 8 | 2.0 | 10 | 2.4 | |
Stage X | 11 | 2.7 | 9 | 2.1 |